BMPR2 and pulmonary arterial hypertension: Furthermore, recent studies have revealed for the first time that the lysosomal protease cathepsin L promotes the development of PAH by degrading BMPR2, thereby inducing endothelial cell injury through the BMPR2/caspase-3/GSDME-mediated pyroptosis pathway (66).